Endurance International Group (EIGI) Insider Sells $35,682.40 in Stock

Endurance International Group (NASDAQ:EIGI) insider David C. Bryson sold 4,888 shares of the stock in a transaction on Monday, April 2nd. The shares were sold at an average price of $7.30, for a total value of $35,682.40. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of EIGI stock opened at $7.25 on Friday. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 22.48. Endurance International Group has a 1 year low of $6.20 and a 1 year high of $9.50.

How to Become a New Pot Stock Millionaire

Endurance International Group (NASDAQ:EIGI) last issued its earnings results on Tuesday, February 13th. The software maker reported $0.05 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.15) by $0.20. The company had revenue of $294.25 million during the quarter, compared to analyst estimates of $289.22 million. Endurance International Group had a negative return on equity of 130.24% and a negative net margin of 9.12%. The firm’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter last year, the business posted ($0.26) EPS. equities research analysts anticipate that Endurance International Group will post -0.19 EPS for the current year.

Several analysts have recently commented on EIGI shares. BidaskClub upgraded Endurance International Group from a “strong sell” rating to a “sell” rating in a report on Thursday, February 22nd. Morgan Stanley decreased their price objective on Endurance International Group from $8.00 to $7.75 and set an “underweight” rating for the company in a report on Wednesday, February 14th. Goldman Sachs started coverage on Endurance International Group in a report on Friday, March 23rd. They set a “sell” rating and a $8.50 price objective for the company. Credit Suisse Group decreased their price objective on Endurance International Group from $10.00 to $9.00 and set an “outperform” rating for the company in a report on Wednesday, February 14th. Finally, Zacks Investment Research lowered Endurance International Group from a “hold” rating to a “sell” rating in a research note on Wednesday, January 10th. Five analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $8.04.

A number of hedge funds have recently modified their holdings of EIGI. Okumus Fund Management Ltd. raised its stake in Endurance International Group by 4.9% in the 4th quarter. Okumus Fund Management Ltd. now owns 12,801,052 shares of the software maker’s stock worth $107,529,000 after acquiring an additional 601,025 shares during the last quarter. Renaissance Technologies LLC raised its stake in Endurance International Group by 48.6% in the 4th quarter. Renaissance Technologies LLC now owns 1,708,800 shares of the software maker’s stock worth $14,354,000 after acquiring an additional 559,200 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Endurance International Group by 206.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 439,559 shares of the software maker’s stock worth $3,604,000 after acquiring an additional 296,037 shares during the last quarter. Millennium Management LLC raised its stake in Endurance International Group by 165.8% in the 4th quarter. Millennium Management LLC now owns 337,639 shares of the software maker’s stock worth $2,836,000 after acquiring an additional 210,616 shares during the last quarter. Finally, First Trust Advisors LP raised its stake in Endurance International Group by 3.4% in the 4th quarter. First Trust Advisors LP now owns 4,743,982 shares of the software maker’s stock worth $39,849,000 after acquiring an additional 157,922 shares during the last quarter. Institutional investors own 89.57% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/3338320/endurance-international-group-eigi-insider-sells-35682-40-in-stock.html.

Endurance International Group Company Profile

Endurance International Group Holdings, Inc, together with its subsidiaries, provides cloud-based platform solutions for small-and medium-sized businesses worldwide. The company operates in three segments: Web Presence, Domain, and Email Marketing. It offers Web hosting services, including entry-level shared hosting, and virtual private server and dedicated hosting solutions; Website building tools that enable subscribers with varying degrees of technical sophistication to create a Web presence; domain registration, management, and resale services; malware protection solutions to protect subscribers' Websites from viruses, malicious code, and other threats; and backup control solutions that enable subscribers to schedule, maintain, manage, and restore backups of their online data and Websites.

Insider Buying and Selling by Quarter for Endurance International Group (NASDAQ:EIGI)

Receive News & Ratings for Endurance International Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endurance International Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Alphabet  and The Competition Critical Comparison
Alphabet and The Competition Critical Comparison
Comparing Angle Energy  and Crusader Energy Group
Comparing Angle Energy and Crusader Energy Group
Brokerages Set Marriott International  Price Target at $128.50
Brokerages Set Marriott International Price Target at $128.50
Analysts Set Varian Medical Systems  PT at $108.75
Analysts Set Varian Medical Systems PT at $108.75
Head-To-Head Analysis: NXT-ID  versus Allegion
Head-To-Head Analysis: NXT-ID versus Allegion
Adamis Pharmaceuticals Corp  Receives Consensus Rating of “Hold” from Analysts
Adamis Pharmaceuticals Corp Receives Consensus Rating of “Hold” from Analysts


© 2006-2018 Ticker Report. Google+.